Skip to content
Research Article Open access CC BY 4.0

Novel Salts of Sunitinib an Anticancer Drug with Improved Solubility

Sangeeta Sangwan, Tapas Panda, Ram Thiamattam, Sharwan K. Dewan, Rajesh K. Thaper

International Research Journal of Pure and Applied Chemistry · pp. 352–365 · Published 19 Dec 2014

10.9734/IRJPAC/2015/13578

Abstract

Polymorph, co-crystal and salt screening experiments were carried out to identify novel solid forms with the improved physicochemical properties, particularly water solubility in the present case. Co-crystal formation was evaluated with urea and nicotinamide. These coformers do not have any ionic groups that favor the formation of salts. Sunitinib malate salt is being currently sold in the market. It is poorly soluble in water. Salt screening experiments were conducted with adipic acid, glutaric acid, nicotinic acid, 4-hydroxy benzoic acid and saccharin. The salts with 1:1 ratios were obtained with these acids, except for adipic acid, which yielded a 2:1 solid form. The solubility of these salts in deionized water was found to be 6 to 10 times greater than that of the marketed salt (sunitinib malate). Reversible Z-E isomerization was also well thought-out especially in presence of light and the isomerization was checked by HPLC. Formation of undesired E-isomer was additionally confirmed by 1H NMR. This observation has implications in the solubility study of sunitinib salt samples using HPLC method.  

Sunitinib photosensitive novel salts conformers solubility HPLC

References (17)

  1. 1 Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma [DOI]
  2. 2 Pharmaceutical Cocrystals and Their Physicochemical Properties [DOI]
  3. 3 Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates [DOI]
  4. 4 Polymorphism in Molecular Crystals [DOI]
  5. 5 The role of cocrystals in pharmaceutical science [DOI]
  6. 6 Characterization of piroxicam crystal modifications [DOI]
  7. 7 Sunitinib therapy for metastatic renal cell carcinoma: recommendations for management of side effects [DOI]
  8. 8 Identifying the Stable Polymorph Early in the Drug Discovery-Development Process [DOI]
  9. 9 Polymer-Induced Heteronucleation of Tolfenamic Acid: Structural Investigation of a Pentamorph [DOI]
  10. 10 Impact of the counterion on the solubility and physicochemical properties of salts of carboxylic acid drugs [DOI]
  11. 11 Formation of Tubular Crystals of Pharmaceutical Compounds [DOI]
  12. 12 Additive-Induced Metastable Single Crystal of Mefenamic Acid [DOI]
  13. 13 Solvent Diversity in Polymorph Screening [DOI]
  14. 14 Influence of Additives on Nucleation of Vanillin: Experiments and Introductory Molecular Simulations [DOI]
  15. 15 Stabilization of a Metastable Polymorph of 4-Methyl-2-nitroacetanilide by Isomorphic Additives [DOI]
  16. 16 Reversible Z-E Isomerism and Pharmaceutical Implications for SU5416 [DOI]
  17. 17 Pharmacokinetics and pharmacodynamics of sunitinib for the treatment of advanced pancreatic neuroendocrine tumors [DOI]

Cited by 10

An investigation into Sunitinib malate nanoparticle production by US- RESOLV method: Effect of type of polymer on dissolution rate and particle size distribution

Fariba Razmimanesh, Gholamhossein Sodeifian, Seyed Ali Sajadian · The Journal of Supercritical Fluids · 2021

Organic salts as a tool for pharmaceutical ingredient purification: Bibliographic review

Juan Carlos Ortiz Lara · Revista Colombiana de Ciencias Químico-Farmacéuticas · 2024

Drug-like properties of tyrosine kinase inhibitors in ophthalmology: Formulation and topical availability

Phatsawee Jansook, Thorsteinn Loftsson, Einar Stefánsson · International Journal of Pharmaceutics · 2024

Showing 4 of 10 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

62

Page views

0

PDF downloads

24

Outbound clicks

10

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.